C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
05/2011
05/19/2011	WO2011058509A1 Method and kit for the prevention and/or the monitoring of chemioresistance of leukaemia forms
05/19/2011	WO2011058368A1 Immune system modulating composition
05/19/2011	WO2011058087A1 Immunoassay for assessing related analytes of different origin
05/19/2011	WO2011058055A1 Anti-trypanosome therapeutic and diagnostic applications
05/19/2011	WO2011057788A1 Antibodies specific for claudin 6 (cldn6)
05/19/2011	WO2011057437A1 Anti-epidemic growth factor receptor antibody and encoding genes and uses thereof
05/19/2011	WO2011057436A1 Anti-epidermal growth factor receptor antibodies and uses thereof
05/19/2011	WO2011057435A1 Anti-epidermal growth factor receptor antibodies and uses thereof
05/19/2011	WO2011004028A3 Tlr3 binding agents
05/19/2011	WO2010128407A3 Anti-il-17f antibodies and methods of use thereof
05/19/2011	WO2009046407A3 B7 FAMILY MEMBER zB7H6 AND RELATED COMPOSITIONS AND METHODS
05/19/2011	US20110119786 Inositol polyphosphate 2-kinase genes and uses thereof
05/19/2011	US20110118446 Methods and compositions for antibody production
05/19/2011	US20110118445 Inhibitor protein of the wnt signal pathway
05/19/2011	US20110118444 Binding molecules
05/19/2011	US20110118443 Antibody design using anti-lipid antibody crystal structures
05/19/2011	US20110118181 Pcsk9 inhibitors and methods of use thereof
05/19/2011	US20110118129 Method for predicting therapy responsiveness in basal like tumors
05/19/2011	US20110117671 Method for Stabilizing Microparticles Having Reactive Substance Bound Thereto, and Reagent Containing the Microparticles
05/19/2011	US20110117670 Multiplex immunoassays for hemoglobin, hemoglobin variants, and glycated forms
05/19/2011	US20110117626 Hydrophobic Interaction Chromatography Membranes, and Methods of Use Thereof
05/19/2011	US20110117602 Human antibody capable of inducing apoptosis
05/19/2011	US20110117572 Antibody Specific to the AIMP2-DX2
05/19/2011	US20110117558 Diagnosis of hereditary spastic paraplegias (hsp) by identification of a mutation in the zfyve26 gene or protein
05/19/2011	US20110117130 Method of diagnosing and treating Ehrlichia
05/19/2011	US20110117118 Molecules, compositions, methods and kits for applications associated with flaviviruses
05/19/2011	US20110117116 Nucleic acids encoding a house dust mite allergen, der p iii, and uses therefor
05/19/2011	US20110117114 Neovascular-Targeted Immunoconjugates
05/19/2011	US20110117113 Immunoglobulin single variable domain directed against human cxcr4 and other cell associated proteins and methods to generate them
05/19/2011	US20110117110 Anti-egfr antibodies and their uses
05/19/2011	US20110117109 Cytomegalovirus disintegrin-like peptides
05/19/2011	US20110117105 Method of treating immune disease using b-cell antibodies
05/19/2011	US20110117104 Monoclonal antibody specific to anthrax toxin
05/19/2011	US20110117103 Anti-sweat antigen monoclonal antibody
05/19/2011	US20110117100 Compositions and methods for diagnosis, stratification and treatment of amyloidogenic diseases
05/19/2011	US20110117099 Inhibiting staphylococcus epidermidis infections
05/19/2011	US20110117096 Methods for Identifying Tumors That are Responsive to Treatement With Anti-ErbB2 Antibodies
05/19/2011	US20110117095 Growth factor htter36
05/19/2011	US20110117093 Antibodies that immunospecifically bind to b lymphocyte stimulator protein
05/19/2011	US20110117092 Compositions and methods for inhibiting g-csfr
05/19/2011	US20110117091 Humanization of rabbit antibodies using a universal antibody framework
05/19/2011	US20110117090 Adam-15 antibodies and immunogenic peptides
05/19/2011	US20110117089 BCR-Complex-Specific Antibodies And Methods Of Using Same
05/19/2011	US20110117087 Method for the production of a glycosylated immunoglobulin
05/19/2011	US20110117086 Monoclonal antibodies to progastrin and their uses
05/19/2011	US20110117080 Anti-REG4 Antibodies
05/19/2011	US20110117079 Therapeutic dll4 binding proteins
05/19/2011	US20110117023 Contrast agent for photoacoustic imaging and photoacoustic imaging method using the same
05/19/2011	US20110117013 Compositions against cancer antigen liv-1 and uses thereof
05/19/2011	CA2780935A1 Material and methods for treating or preventing her-3 associated diseases
05/19/2011	CA2780708A1 Single-chain variable fragment (scfv) able to recognize and bind cd99 human protein
05/19/2011	CA2780319A1 A method of promoting dendritic spine density
05/19/2011	CA2780208A1 Therapeutic and diagnostic applications against trypanosomosis
05/19/2011	CA2780024A1 Immunoassay for assessing related analytes of different origin
05/19/2011	CA2779683A1 Anti-c-mpl antibodies
05/19/2011	CA2778953A1 Compositions, kits, and methods for the diagnosis, prognosis, monitoring, treatment and modulation of post-transplant lymphoproliferative disorders and hypoxia associated angiogenesis disorders using galectin-1
05/19/2011	CA2778809A1 Antibody glycosylation variants
05/19/2011	CA2777825A1 Anti-egfr antibodies and their uses
05/19/2011	CA2775373A1 Antibodies specific for claudin 6 (cldn6)
05/18/2011	EP2322933A1 Diagnosis of carcinomas
05/18/2011	EP2322929A1 Diagnostics, drug screening and treatment for cancer
05/18/2011	EP2322625A1 Monoclonal antibody against hepatitis E virus or its fragment with binding activity and use thereof
05/18/2011	EP2322624A2 Method for isolation of soluble polypeptides
05/18/2011	EP2322623A2 Method for isolation of soluble polypeptides
05/18/2011	EP2322622A2 Method for isolation of soluble polypeptides
05/18/2011	EP2322621A2 Method for isolation of soluble polypeptides
05/18/2011	EP2322610A1 Anti-human clcp1 antibody and use thereof
05/18/2011	EP2322562A1 Monoclonal antibody, and immunoassay using same
05/18/2011	EP2322561A1 Anti-NIK antibodies and uses thereof
05/18/2011	EP2322560A1 Anti-mesothelin antibodies
05/18/2011	EP2322559A2 Neoplasm specific antibodies and uses thereof
05/18/2011	EP2322558A1 Antibodies directed against glycoprotein VI and uses thereof
05/18/2011	EP2322557A2 Compositions and methods for treating proliferative disorders
05/18/2011	EP2322556A1 Humanized anti-beta7 antagonists and uses therefor
05/18/2011	EP2322555A1 Antibodies specific for claudin 6 (CLDN6)
05/18/2011	EP2322554A1 Composition comprising an anti-TNF-alpha domain antibody for the treatment of rheumatoid arthritis
05/18/2011	EP2322553A2 Interleukin-17F antibodies and other IL-17F signaling antagonists and uses therefor
05/18/2011	EP2322552A2 IL-1beta binding antibodies and fragments thereof
05/18/2011	EP2322551A2 Compositions comprising Anti-IGF-1R Antibodies and Methods for their Production
05/18/2011	EP2322550A1 Compositions comprising anti-IGF-1R Antibodies and Methods for obtaining said Antibodies
05/18/2011	EP2322549A1 Connective tissue growth factor antibodies
05/18/2011	EP2322547A1 Myeloid cell-specific lectin
05/18/2011	EP2322544A2 Differential in tumour gene products and use of same
05/18/2011	EP2322543A1 Antigenic polypeptide usable as therapeutic agent for malignant neoplasm
05/18/2011	EP2322539A2 A method for identification, isolation and production of antigens to a specific pathogen
05/18/2011	EP2322229A2 Remodelling and glycoconjugation of Granulocyte Colony Stimulating Factor (G-CSF)
05/18/2011	EP2322221A1 Pharmaceutical composition for treatment and prevention of cancer
05/18/2011	EP2322220A1 Therapeutic agent or preventive agent for osteoarthritis
05/18/2011	EP2322218A1 Methods of modulating CD200 receptors
05/18/2011	EP2322217A2 Combination treatment for non-hematologic malignancies using an anti-IGF-1R antibody
05/18/2011	EP2322216A1 A preventive or therapeutic agent for sensitized T cell-mediated diseases comprising IL-6 antagonist as an active ingredient
05/18/2011	EP2322215A2 Combination treatment for non-hematologic malignancies using an anti-IGF-1R antibody
05/18/2011	EP2322214A1 Immunogenic recombinant antibody
05/18/2011	EP2322213A1 Cancerous disease modifying antibodies
05/18/2011	EP2322209A2 Tumor specific oligosaccharide epitopes and use thereof
05/18/2011	EP2322206A2 Mutated netrin 1, fragments thereof and uses thereof as drugs
05/18/2011	EP2322203A2 Compositions and methods for the treatment of immune related diseases
05/18/2011	EP2322202A2 Compositions and methods for the treatment of immune diseases
05/18/2011	EP2322201A2 Compositions and methods for the treatment of immune related diseases
05/18/2011	EP2322200A2 Compositions and methods for the treatment of immune related diseases

1 ... 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 ... 1494